All Blogs

emerging-vaccines-for-clostridium-difficile-infection-treatment

Jan 30, 2023

Innovative Vaccines for Clostridium difficile Infection Treatment in the Horizon


Latest MedTech News and Updates for Tandem, NeuroMetrix, Cytovale, icotec ag

Jan 26, 2023

Tandem Acquires AMF Medical; NeuroMetrix Launched DPNCheck 2.0 Device; FDA Approves Cytovale’s IntelliSep Sepsis Test; FDA Clearance for the Ø 4.5mm VADER Pedicle Screws; Pie Medical Imaging’s vFFR FASTIII Trial; Hip Innovation Technology Announced Initiation Investigational Device Exemption Study


Aesthetic Implants Market Outlook , Key Trends and Developments

Jan 25, 2023

Aesthetic Implants Market : Evaluating the Major Factors Creating the Demand for Aesthetic Products


Lupus Nephritis Treatment Market Outlook and Emerging Therapies

Jan 27, 2023

Lupus Nephritis: A SILENT but SEVERE Systemic Lupus Erythematosus Manifestation


Latest Pharma News and Updates for BeiGene, Seagen, Alnylam, Roche, Astellas

Jan 24, 2023

BeiGene’s Brukinsa Approval; FDA Approval to Seagen’s TUKYSA; NICE Recommends Alnylam’s Amvuttra; FDA Approves Brenzavvy for Type 2 Diabetes; Roche’s Tecentriq to be Filed for Early-stage Liver Cancer; FDA Lifts Hold on Astellas’ Pompe Gene Therapy


MedTech News for Cardiovascular Systems, Koneksa, Medcura, Abbott, Enovis, Bausch + Lomb, AcuFocus

Jan 19, 2023

First Patient Enrolled in Kaizen Clinical Study in Japan; Koneksa’s At-Home Mobile Spirometry Clinical Trial; Medcura’s LifeGel™ Absorbable Surgical Hemostat; FDA Clearance to Abbott’s NAVITOR; Enovis’s DynaClip Delta™ and DynaClip Quattro™ bone staples; Bausch + Lomb Acquired AcuFocus


uncomplicated-uti-treatment-landscape

Jan 23, 2023

Uncomplicated UTI Treatment: Challenges and Opportunities in the Market


Drug Delivery Devices Market Outlook and Key Developments

Jan 18, 2023

How Are Innovations in Drug Delivery Devices Solving the Complex Challenges in the Market?


emerging-therapies-for-ptsd-treatment

Jan 20, 2023

Post-traumatic Stress Disorder (PTSD) Treatment: Will the Emerging Therapies Succeed in Curing this Invisible Wound?


Pharma News and Updates for Luye Pharma, AstraZeneca, Oramed, Eisai, AbbVie

Jan 17, 2023

FDA Approves Luye’s Rykindo; EU Approves AstraZeneca’s Tezspire; Oramed Announces Trial Results of ORMD-0801; Eisai and Biogen File Lecanemab in the EU; AbbVie and Anima Biotech Announce Collaboration; AstraZeneca’s Avillion Receives FDA Approval